Sarepta Therapeutics

SRPT

5 Followers

$36.28

-0.67%

-$0.24

6 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

SRPT Fair Price

$58.66

Undervalued by 131.1%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Sarepta Therapeutics, Inc. (SRPT) is an American biopharmaceutical company focused on research, development, and commercialization of drugs for the treatment of rare genetic diseases. The company specializes in treating muscular dystrophies caused by genetic mutations. Sarepta Therapeutics develops innovative therapies based on gene therapy and RNA technologies, which have the potential to provide new treatment options for patients with rare genetic diseases. With its successful research programs and collaboration with renowned experts in the field, the company has become a significant player in the field of muscular dystrophy treatment. Shares of Sarepta Therapeutics, Inc. (SRPT) can represent an interesting investment opportunity for those seeking exposure to the biotechnology industry with a focus on treating rare genetic diseases and innovative therapeutic approaches.

Feed

There are no posts to show right now.